Worley Gordon, Crissman Blythe G, Cadogan Emily, Milleson Christie, Adkins Deanna W, Kishnani Priya S
Division of Pediatric Neurology (Developmental Medicine), Durham, NC, USA
Division of Genetics and Metabolism, Durham, NC, USA.
J Child Neurol. 2015 Aug;30(9):1147-52. doi: 10.1177/0883073814554654. Epub 2014 Nov 3.
Over a 10-year period in a Down syndrome Clinic, 11 children and adolescents were encountered with a history of new-onset (8) or worsening (3) autistic characteristics. Ten of the 11 (91%) had cognitive decline to a dementia-like state and 9 of the 11 (82%) new-onset insomnia. The mean age at which symptoms developed was 11.4 years (standard deviation = 3.6 years; range 5-14 years), an older age than usual for autistic regression in Down syndrome. Ten of 11 cases (91%) had elevated ("positive") thyroperoxidase antibody titers compared to only 5 of 21 (23%) age-matched control subjects with Down syndrome (P < .001). At follow-up at a mean age of 20.7 years (standard deviation = 3.9 years), 8 of the 11 (73%) were at least somewhat better. Down syndrome disintegrative disorder seems an appropriate name for this newly recognized clinical association, which may be due to autoimmunity.
在一家唐氏综合征诊所的10年期间,遇到了11名儿童和青少年,他们有新发(8例)或加重(3例)的自闭症特征病史。11名中有10名(91%)出现认知衰退至痴呆样状态,11名中有9名(82%)新发失眠。症状出现的平均年龄为11.4岁(标准差=3.6岁;范围5 - 14岁),这一年龄比唐氏综合征中自闭症退行通常出现的年龄要大。11例中有10例(91%)甲状腺过氧化物酶抗体滴度升高(“阳性”),而在21名年龄匹配的唐氏综合征对照受试者中只有5例(23%)升高(P <.001)。在平均年龄20.7岁(标准差=3.9岁)的随访中,11名中有8名(73%)至少有所好转。唐氏综合征退行性障碍似乎是这种新认识的临床关联的一个恰当名称,其可能归因于自身免疫。